Potent and selective, ATP-competitive glycogen synthase kinase-3 (GSK-3) inhibitor (IC50
values are 5, 83, 300, 320 and > 10 000 nM at GSK-3, CDK5/p25, CDK2/cyclin A, CDK1/cyclin B and other common kinases respectively). Maintains self-renewal and pluripotency in embryonic stem cells via activation of the Wnt signaling pathway in vitro
; also promotes proliferation and dedifferentiation in cardiomyocytes. Negative control
available (Cat. No. 3873).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Other Product-Specific Information:
The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes.
Tseng et al.
GSK-3-selective inhibitors derived from tyrian purple indirubins.
Meijer et al.
Structural basis for the synthesis of indirubins as potent and selective inhibtors of glycogen synthase kinase-3 and cyclin dependent kinases.
Polychronopoulos et al.
The citations listed below are publications that use Tocris products. Selected citations for BIO include:
Showing Results 1 - 10 of 10